No Data
HSBC Adjusts Price Target on AbbVie to $275 From $265, Maintains Buy Rating
AbbVie Conference: Year-End HS Readouts, SubQ SKYRIZI Data and New IBD Combo Roadmap in Focus
1 No-Brainer Dividend Stock to Buy on the Dip
3 Dividend Stocks to Hold for the Next 20 Years
Morgan Stanley's Q4 holdings maintained a focus on core technology, with Apple topping the list and positions in index ETFs declining.
Morgan Stanley's Q4 portfolio changes reflect the characteristics of 'maintaining a focus on core technology, reducing index exposure, and enhancing active selection capabilities.'
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off